Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001193125-25-207432

CHIEF EXECUTIVE OFFICER bought 92,233 shares at an average $1.08 ($99,352)

From the SEC's structured data for this filing

Trades in this filing

Lettmann Jason · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-16 Purchase : show line 1 in the form +21,070 $1.07 $22,461 233,958 D
2025-09-17 Purchase : show line 2 in the form +71,163 $1.08 $76,892 305,121 D
Open-market purchases · 92,233 sh · avg $1.08 · $99,352
Loading xslF345X05/ownership.xml…